Abstract:Dear Editor: The European Baseline Series (EBS) of contact allergens is used throughout Europe as a screening test to diagnose contact allergy as a proxy for allergy contact dermatitis and other hypersensitivity skin diseases (1). Parabens are alkyl esters of p-hydroxybenzoic acid with antimicrobial effects used as preservatives in cosmetics, foods, and drugs that have been included in the so called "baseline series" (2) for more than 40 years. Parabens, which are considered allergologically safe biocides and are classified as safe by the US Food and Drug Administration (FDA) and the Scientific Committee on Consumer Safety (SCCS) in Europe (2-4), are frequently present in cosmetics (5). Despite extensive and progressively expanding use worldwide, studies confirm that parabens are seldom responsible for allergic contact dermatitis to cosmetics, and the frequency of sensitivity to parabens has been low and stable for many decades (2). The frequency of positive reactions to paraben mix is less than 0.5% in most clinical series, although it seems that when it occurs it is often of high clinical relevance (6). Nevertheless, several authors have stated that these patients rarely or never have to avoid foods or cosmetics that contain parabens to control their dermatitis (2). Paraben allergy most frequently occurs in patients with long-lasting stasis dermatitis or disruption of skin integrity, with high use of topical drugs, and in those who do not get better under normal treatment and/or skin care (5). The EBS has been periodically adapted by the European Environmental and Contact Dermatitis Research Group (EECDRG) and the European Society of Contact Dermatitis (ESCD), according to frequency studies, but ensuring that tested haptens remain relevant (1). Bruze et al. recommend that haptens should be considered for inclusion in a baseline series when the contact allergy prevalence is 0.5-1.0% or above (7). So, why not exclude paraben mix from the EBS? We analysed all the EBS tests performed at our institution in the last 21 years (2000-2020) to evaluate the frequency of positive reactions to paraben mix 16% pet (Chemotechnique diagnostics, Vellinge Sweden). In total, 5885 patients were patch tested (MOAHLFA index - Table 1), of whom 29 (10 men and 19 women) patients presented with a positive reaction (1+ or more according to ESCD guidelines) to paraben mix (0.49%), with positivity rates varying between 1.79% and 0.0% and progressively falling for the past 20 years (Figure 1). Present or past clinical relevance was found in 19/29 (65.5%) patients (6 men and 13 women), and was related to the use of topical drugs in 16 patients (55.2%) and cosmetics in three patients (10.3%). Paraben reactions occurred mostly in patients with history of leg ulcer, leg dermatitis, and/or chronic venous insufficiency, which is in agreement with the overrepresentation of the group of patients with leg dermatitis compared with the whole population tested (Table 1). The proportion of patients with positive reactions to paraben mix was significantly higher in patients with leg dermatitis compared with patients without leg dermatitis (P<0.05), as well in patients aged >40 (P<0.05), in whom these leg comorbidities are more frequent. Additionally, the higher number of reactions frequently coincided with the highest number of patients with leg dermatitis patch tested in the same year (Figure 1). Cosmetics were considered the causative factor in only three patients, which explains the identical percentage of facial and atopic dermatitis in the paraben mix positive group and the total population tested. As expected, both hand and occupational dermatitis were underrepresented in the group of positive reactions to parabens. In 34.5% of the patients, positive tests were considered not relevant or of unknown relevance. Therefore, in total only 0.32% of all paraben mix reactions were clinically relevant. Patch test reactivity to paraben mix of 0.49% supports the ongoing discussion that parabens should not continue in the baseline series, a position that is further strengthened by the fact that only 0.32% represent relevant reactions (8). As the most relevant sensitizations are related to topical medications and, less frequently, from cosmetics, paraben mix should be part of the topical drugs and cosmetic series.

Serum analysis in women and in vitro skin assay for the assessment of exposure to parabens in antiperspirants

Simultaneous Determination of Phthalates and Parabens in Cosmetic Products by Gas Chromatography/Mass Spectrometry Coupled with Solid Phase Extraction

Urinary concentrations of parabens and serum hormone levels, semen quality parameters, and sperm DNA damage

Into the toxicity potential of an array of parabens by biomimetic liquid chromatography, cell viability assessments and in silico predictions

Exposure of Chinese adult females to parabens from personal care products: Estimation of intake via dermal contact and health risks

Parabens in urine of children and adolescents in Germany - human biomonitoring results of the german environmental survey 2014-2017 (GerES V)

An in vitro assessment for human skin exposure to parabens using magnetic solid phase extraction coupled with HPLC

Trace analysis of parabens preservatives in drinking water treatment sludge, treated, and mineral water samples

Correlation study of parabens in urine, serum, and seminal plasma of adult men in Beijing, China

The Estrogenicity of Methylparaben and Ethylparaben at Doses Close to the Acceptable Daily Intake in Immature Sprague-Dawley Rats.

Review of the safety of application of cosmetic products containing parabens

Urinary Concentrations of Parabens in a Population of Iranian Adolescent and Their Association with Sociodemographic Indicators

Urinary concentrations of parabens and their association with demographic factors: A population-based cross-sectional study

[Determination of ten bisphenols and five parabens in urine by solid supported liquid-liquid extraction and liquid chromatography-tandem mass spectrometry]

Biomonitoring parabens in dogs using fur sample analysis - Preliminary studies

Ultrasound- and Vortex-Assisted Dispersive Liquid-Liquid Microextraction of Parabens from Personal Care Products and Urine, Followed by High-Performance Liquid Chromatography

Risk assessment of parabens in a transcriptomics-based in vitro test

Parabens: Potential impact of Low-Affinity Estrogen receptor Binding chemicals on Human health

Urinary paraben concentrations and their implications for human exposure in Iranian pregnant women

Electro-assisted liquid phase microextraction for the determination of parabens and their main metabolites in maternal urine and amniotic fluid samples

Should Paraben Mix Be Removed from The European Baseline Series